脑肿瘤药物市场报告：2030 年趋势、预测与竞争分析

脑肿瘤治疗药物的趋势与预测

2024年至2030年，全球脑肿瘤治疗市场预计将以8.7%的复合年增长率成长。该市场的主要驱动因素是吸烟率上升、人口老化、压力和电磁辐射暴露。全球脑肿瘤治疗市场前景未来性，医院药局和零售/线上药局市场充满机会。

脑肿瘤治疗药物按细分市场

该研究包括按治疗、适应症、分销管道和地区对全球脑肿瘤药物的预测。

脑肿瘤药物市场洞察

Lucintel 预测，化疗（辅助性治疗）在预测期内仍将是最大的细分市场。

医院药局将继续占据该市场的很大一部分，因为治疗脑肿瘤的药物是处方药，必须在医院内使用。

由于有利的报销政策和新药上市的增加，北美在预测期内可能仍然是最大的地区。

常问问题

Q1.市场成长预测是多少：

A1. 2024年至2030年，全球脑肿瘤治疗药物市场预计将以8.7%的复合年增长率成长。

Q2. 影响市场成长的关键驱动因素是：

A2. 该市场的主要驱动因素是吸烟率上升、人口老化、压力和电磁辐射暴露。

Q3.市场的主要细分市场是：

A3.脑肿瘤治疗药物市场前景广阔，医院药局市场和零售/网路药局市场都有机会。

Q4.市场的主要企业是：

A4. 生产脑肿瘤治疗药物的主要企业如下：

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5.未来最大的细分市场是什么？

A5.Lucintel 预计化疗（辅助性治疗）在预测期内仍将是其最大的细分市场。

Q6.未来五年预计哪些地区的市场成长最大？

A6. 由于有利的报销政策和新药市场投放的增加，北美在预测期内仍然是最大的地区。

Q7. 可以客製化报告吗？

A7。

目录

第一章执行摘要

第二章全球脑肿瘤药物市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球脑肿瘤治疗药物市场趋势（2018-2023）与预测（2024-2030）
• 全球脑肿瘤药物市场：依治疗分类
  • 标靶治疗
  • 化疗
  • 免疫疗法
  • 其他的
• 全球脑肿瘤药物市场：依适应症分类
  • 脑下垂体
  • 脑膜瘤
  • 神经胶质瘤
  • 其他的
• 全球脑肿瘤药物市场：按分销管道
  • 医院药房
  • 零售/网路药房

第四章 2018-2030年区域市场趋势及预测分析

• 全球脑肿瘤药物市场（按地区）
• 北美脑肿瘤药物市场
• 欧洲脑肿瘤药物市场
• 亚太地区脑肿瘤药物市场
• 其他地区脑肿瘤药物市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
• 全球脑肿瘤药物市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球脑肿瘤药物市场的产能
  • 全球脑肿瘤药物市场的合併、收购与合资
  • 认证和许可

第七章主要企业概况

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Trends and Forecast

The future of the global brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets. The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are rising prevalence of smoking, increasing aging population, and stress and exposure to electromagnetic radiation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Brain Tumor Drug by Segment

The study includes a forecast for the global brain tumor drug by therapy, indication, distribution channel, and region.

Brain Tumor Drug Market by Therapy [Shipment Analysis by Value from 2018 to 2030]:

• Targeted Therapy
• Chemotherapy
• Immunotherapy
• Others

Brain Tumor Drug Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

• Pituitary
• Meningioma
• Glioma
• Others

Brain Tumor Drug Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail & Online Pharmacy

Brain Tumor Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Brain Tumor Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies brain tumor drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the brain tumor drug companies profiled in this report include-

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Brain Tumor Drug Market Insights

Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Within this market, hospital pharmacy will remain larger segment as drugs designed to treat the condition are prescribed and necessitate administration within hospital settings.

North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Features of the Global Brain Tumor Drug Market

Market Size Estimates: Brain tumor drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Brain tumor drug market size by therapy, indication, distribution channel, and region in terms of value ($B).

Regional Analysis: Brain tumor drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapy, indication, distribution channels, and regions for the brain tumor drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the brain tumor drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for brain tumor drug market?

Answer: The global brain tumor drug market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the brain tumor drug market?

Answer: The major drivers for this market are rising prevalence of smoking, increasing aging population and stress and exposure to electromagnetic radiation.

Q3. What are the major segments for brain tumor drug market?

Answer: The future of the brain tumor drug market looks promising with opportunities in the hospital pharmacy and retail & online pharmacy markets.

Q4. Who are the key brain tumor drug market companies?

Answer: Some of the key brain tumor drug companies are as follows:

• Hoffmann-La Roche
• Pfizer
• Novartis
• Amgen
• Merck & Co

Q5. Which brain tumor drug market segment will be the largest in future?

Answer: Lucintel forecasts that chemotherapy will remain the largest segment over the forecast period as it is adjuvant therapy, which is employed for the treatment of brain tumors.

Q6. In brain tumor drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to favorable reimbursement policies and rising launch of new drugs in the market.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the brain tumor drug market by therapy (targeted therapy, chemotherapy, immunotherapy, and others), indication (pituitary, meningioma, glioma, and others), distribution channel (hospital pharmacy and retail & online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Brain Tumor Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Brain Tumor Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Brain Tumor Drug Market by Therapy
  • 3.3.1: Targeted Therapy
  • 3.3.2: Chemotherapy
  • 3.3.3: Immunotherapy
  • 3.3.4: Others
• 3.4: Global Brain Tumor Drug Market by Indication
  • 3.4.1: Pituitary
  • 3.4.2: Meningioma
  • 3.4.3: Glioma
  • 3.4.4: Others
• 3.5: Global Brain Tumor Drug Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail & Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Brain Tumor Drug Market by Region
• 4.2: North American Brain Tumor Drug Market
  • 4.2.1: North American Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.2.2: North American Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.3: European Brain Tumor Drug Market
  • 4.3.1: European Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.3.2: European Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.4: APAC Brain Tumor Drug Market
  • 4.4.1: APAC Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.4.2: APAC Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy
• 4.5: ROW Brain Tumor Drug Market
  • 4.5.1: ROW Brain Tumor Drug Market by Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, and Others
  • 4.5.2: ROW Brain Tumor Drug Market by Distribution Channel: Hospital Pharmacy and Retail & Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Brain Tumor Drug Market by Therapy
  • 6.1.2: Growth Opportunities for the Global Brain Tumor Drug Market by Indication
  • 6.1.3: Growth Opportunities for the Global Brain Tumor Drug Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Brain Tumor Drug Market by Region
• 6.2: Emerging Trends in the Global Brain Tumor Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Brain Tumor Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Brain Tumor Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Hoffmann-La Roche
• 7.2: Pfizer
• 7.3: Novartis
• 7.4: Amgen
• 7.5: Merck & Co